Contact this trialFirst, we need to learn more about you.
EGFR Inhibitor
EGFR Inhibitor for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
This trial will test a new drug on patients with advanced lung cancer who have progressed after other treatments. It will help to understand side effects and how well the drug works on its own.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.